NOTICE: We are experiencing technical issues with Academy members trying to log into the JAND site using Academy member login credentials. We are working to resolve the issue as soon as possible. Alternatively, if you are an Academy member, you can access the JAND site by registering for an Elsevier account and claiming access using the links at the top of the JAND site. Email us at [email protected] for assistance. Thanks for your patience!

Maitake Mushrooms as an Anti-Cancer Agent

      This paper is only available as a PDF. To read, Please Download here.


      LEARNING OUTCOME: The audience will be able to assess current research and study outcomes on the maitake mushroom; be aware of what forms are presently under development for the lay and healthcare market.
      Currently intense research is focused on plant-based compounds for cancer prevention and treatment. An area of highly exciting study are the medicinal mushrooms used for millennia within the “food as medicine” discipline of Oriental medicine
      The maitake mushroom (Gifola frondosa), indigenous to Japan ,but found wild in the United States and known as “chicken of the woods” is promising to be very effective in preventing and treating malignant tumors and HIV. The scientific and marketing departments at a Connecticut mushroom company are developing new products based on the maitake. They cultivate it in Connecticut under strict quality control, assuring a safe domestic product. New products containing the active compounds from the maitake include tablets, teas, and extracts.
      Dietitians and other health professionals are looked to for answers about alternative healing therapies. Our current information provides the latest research results on the maitake mushrooms and how it can be incorporated into cancer-prevention protocols. We are doing market research to see which form would be most effective and accepted by health professionals and their clients.
      These charts (transparencies or posters) show maitake cultivation from spore to finished product; and results of studies on the maitake as an anti-HIV agent.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect